Concomitant bladder cancer and prostate cancer: challenges and controversies

[1]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[2]  E. Compérat,et al.  Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. , 2017, European urology.

[3]  Maximilian Burger,et al.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.

[4]  C. Morash,et al.  Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer , 2016, Virchows Archiv.

[5]  J. Buatti,et al.  Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival , 2016, Prostate international.

[6]  P. Carroll,et al.  Active surveillance for prostate cancer: a narrative review of clinical guidelines , 2016, Nature Reviews Urology.

[7]  J. Pow-Sang,et al.  Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer. , 2015, The Journal of urology.

[8]  F. Roos,et al.  Concomitant Gleason Score ≥7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy , 2015, International Urology and Nephrology.

[9]  Rodolfo Montironi,et al.  Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series , 2015, The Prostate.

[10]  F. Boccardo,et al.  Prostatic and urothelial metastasis in the same lymph node: a case report. , 2015, Analytical and quantitative cytopathology and histopathology.

[11]  Kotaro Suzuki,et al.  Androgen deprivation therapy prevents bladder cancer recurrence , 2014, Oncotarget.

[12]  L. Bubendorf,et al.  Incidental prostate cancer prevalence at radical cystoprostatectomy—importance of the histopathological work-up , 2014, Virchows Archiv.

[13]  Choung-Soo Kim,et al.  Is Bladder Tumor Location Associated with Prostate Cancer Detection after Intravesical Bacillus Calmette-Guérin Instillation? , 2014, PloS one.

[14]  M. Najoui,et al.  Synchronous primary malignancies of the male urogenital tract. , 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[15]  M. Colecchia,et al.  Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: our experience in 242 cases , 2014, International Urology and Nephrology.

[16]  A. Masson-Lecomte,et al.  Clinicopathological Characteristics of Incidental Prostate Cancer Discovered from Radical Cystoprostatectomy Specimen: A Multicenter French Study , 2014, Annals of Surgical Oncology.

[17]  S. Daneshmand,et al.  Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens. , 2013, The Journal of urology.

[18]  C. Stief,et al.  Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy , 2013, International journal of urology : official journal of the Japanese Urological Association.

[19]  M. Jordá,et al.  Prognostic implications of partial sampling of radical prostatectomy specimens: comparison of 3 methods. , 2013, The Journal of urology.

[20]  A. Stenzl,et al.  Evolution of the concept of androgen-sensitive bladder cancer , 2013, Scandinavian journal of urology.

[21]  M. Jordá,et al.  Partial Sampling of Radical Prostatectomy Specimens: Detection of Positive Margins and Extraprostatic Extension , 2013, The American journal of surgical pathology.

[22]  A. Hartmann,et al.  Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens , 2012, Virchows Archiv.

[23]  B. Loftus,et al.  The incidence and relevance of prostate cancer in radical cystoprostatectomy specimens , 2012, International Urology and Nephrology.

[24]  M. Kattan,et al.  Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer , 2012, BJU international.

[25]  A. D. De Marzo,et al.  Prostate cancer and inflammation: the evidence , 2012, Histopathology.

[26]  T. H. van der Kwast,et al.  Comparison of incidentally detected prostate cancer with screen‐detected prostate cancer treated by prostatectomy , 2012, The Prostate.

[27]  B. Aytac,et al.  Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens , 2011, World journal of surgical oncology.

[28]  O. Cussenot,et al.  Prostate-sparing cystectomy for bladder cancer: a step toward a dead-end. , 2010, Urology.

[29]  H. Miyake,et al.  Characterization of prostate cancer incidentally detected in radical cystoprostatectomy specimens from Japanese men with bladder cancer , 2010, International Urology and Nephrology.

[30]  A. Stenzl,et al.  Incidental prostate cancer at radical cystoprostatectomy: implications for apex‐sparing surgery , 2010, BJU international.

[31]  Y. Kanai,et al.  Characteristics of prostate cancers found in specimens removed by radical cystoprostatectomy for bladder cancer and their relationship with serum prostate‐specific antigen level , 2009, Cancer science.

[32]  R. Hautmann,et al.  Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer. , 2009, Urologic oncology.

[33]  F. Montorsi,et al.  Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique. , 2009, European urology.

[34]  A. Lopez‐Beltran,et al.  Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? , 2009, BJU international.

[35]  E. Barret,et al.  909 ONCOLOGICAL EVALUATION OF PROSTATE SPARING CYSTECTOMY: THE MONTSOURIS LONG-TERM RESULTS , 2009 .

[36]  T. H. van der Kwast,et al.  Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant? , 2009, American journal of clinical pathology.

[37]  J. Thüroff,et al.  Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer. , 2008, The Journal of urology.

[38]  S. Campbell,et al.  Current status of prostate-sparing cystectomy. , 2008, Urologic oncology.

[39]  Xiao-dong Jin,et al.  Incidental prostate cancer in radical cystoprostatectomy specimens. , 2008, Asian journal of andrology.

[40]  V. Reuter,et al.  Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. , 2008, European urology.

[41]  R. Montironi,et al.  α-Methylacyl Coenzyme A Racemase, Ki-67, and Topoisomerase IIα in Cystoprostatectomies With Incidental Prostate Cancer , 2007 .

[42]  R. Autorino,et al.  Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis. , 2007, European urology.

[43]  E. Messing,et al.  Promotion of bladder cancer development and progression by androgen receptor signals. , 2007, Journal of the National Cancer Institute.

[44]  Jianfeng Xu,et al.  Inflammation in prostate carcinogenesis , 2007, Nature Reviews Cancer.

[45]  T. Christmas,et al.  Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens , 2007, BJU international.

[46]  J. Chin,et al.  Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens , 2007, BJU international.

[47]  Liang Cheng,et al.  Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. , 2006, Human pathology.

[48]  T. Esen,et al.  Should Prostate Cancer Status Be Determined in Patients Undergoing Radical Cystoprostatectomy? , 2006, Urologia Internationalis.

[49]  R. Montironi,et al.  HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer. , 2006, Human pathology.

[50]  Antonio Lopez-Beltran,et al.  Current practice of Gleason grading of prostate carcinoma , 2006, Virchows Archiv.

[51]  M. Peyromaure,et al.  Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer. , 2005, European urology.

[52]  L. Egevad,et al.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.

[53]  W. See.  Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients , 2005 .

[54]  A. Ruffion,et al.  Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. , 2005, Urology.

[55]  Sam S. Chang,et al.  Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. , 2004, The Journal of urology.

[56]  B. Guillonneau,et al.  Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. , 2002, The Journal of urology.

[57]  R. Hautmann,et al.  Detection and Characterization of Early Prostate Cancer by Six Systematic Biopsies and Fine Needle Aspiration Cytology in Prostates from Bladder Cancer Patients , 2001, European Urology.

[58]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 1999, Journal of the National Cancer Institute.

[59]  S. Groshen,et al.  Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. , 1996, The Journal of urology.

[60]  P. Walsh,et al.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.

[61]  A S Whittemore,et al.  Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.

[62]  B. A. Cook,et al.  Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. , 1988, The Journal of urology.

[63]  H. Mangurten,et al.  A 10-Year Experience , 2017 .

[64]  P. Pepe,et al.  Multiparametric pelvic MRI accuracy in diagnosing clinically significant prostate cancer in the reevaluation of biopsy microfocal tumor. , 2015, Anticancer Research.

[65]  as an Adjunctive Breast Imaging Technology An Evidence-Based Analysis , 2008 .

[66]  Sam S. Chang,et al.  Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. , 2004, The Journal of urology.

[67]  M. Blute,et al.  Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? , 2004, Urologic oncology.

[68]  T. Chun.  Coincidence of bladder and prostate cancer. , 1997, The Journal of urology.

[69]  M. Soloway,et al.  Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. , 1996, European urology.

[70]  M. Terris,et al.  Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. , 1995, Urology.

[71]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[72]  W. Thurston.  The evidence , 1985 .